RIPK1-IN-28
RIPK1-IN-28 (compound 13) is an orally active RIPK1 inhibitor. RIPK1-IN-28 inhibits human I2.1 and Hepa1‐6 cells with IC50s of 0.4 and 1.2 nM, respectively[1].
Product Specifications
CAS Number
2968509-28-4
UNSPSC
12352005
Target
RIP kinase
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
CN1C2=CC(C#CC3CC3)=CC=C2OC[C@@H](C1=O)NC(C4=NN(C5=CC=CC=C5)C(C)=CC4=O)=O
Molecular Formula
C27H24N4O4
Molecular Weight
468.50
References & Citations
[1]An Y, et al. Design and synthesis of pyridazin-4-one derivatives as necroptosis inhibitors. Arch Pharm (Weinheim) . 2025 Jan;358 (1) :e2400594.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880266-500 1x 500 µL
Human IgG Immunoglobulin (IG266), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400304-500 1x 500 µL
CD106 / VCAM1 (B-K9), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741118-500 1x 500 µL
Beta-2-Microglobulin (B2M) (B2M/1118), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471573-100 1x 100 µL
N-Cadherin / Cadherin-2 / CD325 (NCAD) (CDH2/1573), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042123-100 1x 100 µL
Mammaglobin (SCGB2A2) (Breast Cancer Marker) (MGB1/2123R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details